Company Overview and News


Add MRK
to your dashboard

Headline News

Caterpillar, UnitedHealth Lead DJIA Slide Thursday

2017-12-14 247wallst
December 14, 2017: Markets opened higher again Thursday but shares trickled lower throughout the day led by a drop of around 1% in the healthcare and materials sectors. Only consumer discretionary stocks posted a decent gain although tech stocks could also close the day with a tiny improvement. WTI crude oil for January delivery settled at $57.04 a barrel, up 0.8% for the day. February gold added 0. (67-0)

Short Sellers Can’t Make Up Their Minds on Major Pharma

2017-12-12 247wallst
Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug gains FDA approval or passes a clinical trial, there can be big upside. (222-1)

Paratek Pharmaceuticals Set To Explode As The Holy Grail Of Antibiotics Omadacycline Nears FDA Approval

2017-12-12 seekingalpha
Omadacycline has broad spectrum activity and is effective in both an IV and oral form making it ideal for resistant infections. First new class of antibiotics in 30 years. (335-1)

5 Blue-Chip Stocks to Buy in Mid-Turnaround

2017-12-12 investorplace
Blue-chip stocks are pushing higher again on Monday, as the combination of speculative excitement surrounding bitcoin mixes with the holiday spirit and seasonal tailwinds to keep prices marching higher. A solid non-farm payroll report on Friday, the passage of the GOP’s tax plan in the Senate and the avoidance of a government shutdown are all tailwinds as well. (195-0)

Disney, Apple Pace Dow to Monday Gain

2017-12-12 247wallst
December 11, 2017: Markets opened mixed Monday with the DJIA lagging a bit. By mid-afternoon all three major indexes were trading in the green, even if barely. Tech, telecom, and energy sectors were among the day’s leading sectors while industrials and financials lagged. WTI crude oil for January delivery settled at $57.99 a barrel, up 1.1% for the day. February gold dropped 0.1% on the day to settle at $1,246. (189-0)

Merck & Co (MRK) a Sell on Adverse Earnings Momentum

2017-12-08 investorplace
Portfolio Grader currently ranks Merck & Co (NYSE:MRK) a Sell. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week. MRK has maintained this ranking for 2 months. (3-0)

3 Things In Biotech You Should Learn Today: December 8, 2017

2017-12-08 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (3-0)

3 Things In Biotech You Should Learn Today: December 7, 2017

2017-12-07 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (8-0)

Tesaro: Updates To Thesis

2017-12-07 seekingalpha
Shares have lost a quarter of their value since my latest update piece, and technicals continue to look weak. (83-1)

Microsoft, Merck Lead DJIA to Close Flat Wednesday

2017-12-06 247wallst
December 6, 2017: Markets opened slightly lower Wednesday even after a solid ADP report on new jobs. After the strong run-up in equity prices some end-of-the-year profit taking might be in order as well. Stock prices bounced around the break-even line most of the day. WTI crude oil for January delivery settled at $55.96 a barrel, down 2.9% for the day after the EIA reported a big addition in gasoline inventories. (56-0)

3 Things In Biotech You Should Learn Today: December 6, 2017

2017-12-06 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (57-0)

How Pharma And Life Sciences M&A Activity Shows Omeros Corporation Is Extremely Undervalued

2017-12-06 seekingalpha
The potential repatriation of trillions of dollars in capital will help fortify the global pharmaceutical and life sciences M&A activity. (456-1)

Iovance Cell Therapies A Must-Watch For 2018

2017-12-04 seekingalpha
Lead candidate LN-144 is demonstrating promising early phase 2 results for advanced melanoma in front-line resistant patients. (78-0)

Walt Disney Co (DIS) Leads 5 Dividend Stocks Boosting Payouts | InvestorPlace

2017-12-04 investorplace
The S&P 500 Index powered higher last week as Congress appeared to be making progress on a bill to lower corporate taxes. While the stock market continues making new highs, a number of companies have also been moving their dividends higher. (19-0)

Array BioPharma: Expecting Significant Upside In 2018

2017-12-02 seekingalpha
Shares have risen a decent bit since my initial entries, but I believe 2018 holds substantially more upside ahead. (327-1)

CUSIP: 58933Y105